POU2F2激活了Akt/mTOR信号通路,通过促进PIK3CD转录来增强糖尿病病期间的B淋巴细胞功能
Xiaoxia Li1, Shukun Cao2, Xiaolin Zi3
1Department of Medical Laboratory, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.
POU2F2通过激活PIK3CD依赖的Akt/mTOR信号来增强B淋巴细胞活性,从而驱动小鼠糖尿病病 (DKD) 的进展. 沉默PIK3CD可以改善DKD症状和损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
背景情况:
- 酸氨基醇-4,5-双酸3-酶催化子单元三 (PIK3CD) 是淋巴细胞中一个关键的PI3K异型.
- 糖尿病病 (DKD) 涉及复杂的分子通路,影响和B细胞功能.
研究的目的:
- 研究PIK3CD在DKD进展和B淋巴细胞活性中的作用.
- 阐明在DKD中POU2F2和PIK3CD之间的监管关系.
主要方法:
- 使用了非肥胖糖尿病 (NOD) 鼠标模型,使用了lentiviral PIK3CD沉默.
- 通过组织学染色和生物标志物分析评估DKD症状.
- 在B淋巴细胞中使用ChIP和光酶试验研究了POU2F2-PIK3CD相互作用.
主要成果:
- 抑制PIK3CD改善了DKD症状,减少了损伤和纤维化,并禁用了Akt/mTOR通路.
- POU2F2促进PIK3CD转录,激活Akt/mTOR通路并增强B细胞功能.
- POU2F2 敲击抑制了 B 细胞增殖和 IgG 沉积, PIK3CD 过度表达反转了效应.
结论:
- POU2F2通过调解PIK3CD依赖的Akt/mTOR信号激活来驱动DKD的进展.
- 针对POU2F2-PIK3CD轴为DKD提供了一个潜在的治疗策略.
更多相关视频
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
